SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,858,000 | +10.7% | 45,264 | -3.9% | 0.02% | +5.3% |
| Q2 2020 | $8,000,000 | +66.4% | 47,077 | +13.0% | 0.02% | +46.2% |
| Q1 2020 | $4,808,000 | -1.1% | 41,667 | -2.0% | 0.01% | +30.0% |
| Q4 2019 | $4,860,000 | -2.2% | 42,533 | -26.9% | 0.01% | -9.1% |
| Q3 2019 | $4,970,000 | +21.3% | 58,201 | -1.7% | 0.01% | +22.2% |
| Q2 2019 | $4,096,000 | +5.6% | 59,186 | +11.8% | 0.01% | 0.0% |
| Q1 2019 | $3,878,000 | -0.8% | 52,961 | -23.3% | 0.01% | -10.0% |
| Q4 2018 | $3,910,000 | -19.9% | 69,006 | +9.1% | 0.01% | 0.0% |
| Q3 2018 | $4,879,000 | +20.7% | 63,262 | +3.9% | 0.01% | +11.1% |
| Q2 2018 | $4,042,000 | +102.4% | 60,882 | +59.6% | 0.01% | +125.0% |
| Q1 2018 | $1,997,000 | +6.5% | 38,157 | +8.9% | 0.00% | 0.0% |
| Q4 2017 | $1,875,000 | -5.5% | 35,052 | -3.9% | 0.00% | 0.0% |
| Q3 2017 | $1,985,000 | +4.0% | 36,486 | -1.1% | 0.00% | 0.0% |
| Q2 2017 | $1,909,000 | -21.4% | 36,892 | -4.6% | 0.00% | -33.3% |
| Q1 2017 | $2,430,000 | +14.5% | 38,658 | -3.9% | 0.01% | +20.0% |
| Q4 2016 | $2,123,000 | -8.5% | 40,223 | -6.3% | 0.01% | +25.0% |
| Q3 2016 | $2,319,000 | +37.6% | 42,941 | +3.0% | 0.00% | 0.0% |
| Q2 2016 | $1,685,000 | +5.7% | 41,691 | -8.2% | 0.00% | 0.0% |
| Q1 2016 | $1,594,000 | -23.4% | 45,421 | -2.1% | 0.00% | -20.0% |
| Q4 2015 | $2,082,000 | +12.7% | 46,384 | -3.1% | 0.01% | 0.0% |
| Q3 2015 | $1,847,000 | -85.8% | 47,891 | -82.1% | 0.01% | -83.3% |
| Q2 2015 | $12,976,000 | +31.9% | 268,104 | -3.7% | 0.03% | +36.4% |
| Q1 2015 | $9,838,000 | +20.7% | 278,290 | +9.7% | 0.02% | +22.2% |
| Q4 2014 | $8,150,000 | -2.5% | 253,642 | +12.8% | 0.02% | -5.3% |
| Q3 2014 | $8,357,000 | -3.0% | 224,768 | -0.2% | 0.02% | -5.0% |
| Q2 2014 | $8,617,000 | -16.8% | 225,264 | -0.9% | 0.02% | -16.7% |
| Q1 2014 | $10,353,000 | +23.9% | 227,227 | +8.5% | 0.02% | +26.3% |
| Q4 2013 | $8,356,000 | -4.9% | 209,481 | +4.5% | 0.02% | -13.6% |
| Q3 2013 | $8,786,000 | +20.2% | 200,455 | -13.7% | 0.02% | +10.0% |
| Q2 2013 | $7,307,000 | – | 232,272 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |